Reed’s, Inc. Prices $10.0M PIPE at $0.574/Share
Reed’s, Inc. raised $10.0M through a PIPE deal with D&D Source of Life at $0.574 per share, issuing 17,421,602 shares. The transaction is expected to close by Oct. 30, 2026, with proceeds for working capital and corporate purposes.
How this was made

The 30-second read
Why it matters
The PIPE is the first public disclosure of this financing round, providing fresh data for traders.
Market read
New financing event for a micro‑cap biotech, modest cash but dilution risk; limited broader market impact.
What to watch
Potential strategic partnership with D&D Source of Life may bring operational synergies.
Background
Reed's Inc is a micro‑cap biotech focused on regenerative medicine, frequently raising capital to fund R&D.
Ticker impact
Reed's Inc announced a $10.0M private placement at $0.574 per share for 17.4M shares, closing around Oct 30, 2026.
likely downward pressure as market prices in dilution and modest cash infusion
New financing at a low price per share signals need for liquidity and creates dilution, which typically depresses share price in micro‑cap stocks.
Market effects
Limited impact; primarily affects micro‑cap financing trends.
No broader regional effect.
Minimal; confined to Reed's shareholders.
Counterpoint
The cash infusion could enable growth initiatives that outweigh dilution concerns.
Key entities
- CompanyReed's, Inc.
Issuer of the private placement.
- InvestorD&D Source of Life
Major investor participating in the PIPE.

